REED JAN STERN 4

What Happened Reed Jan Stern, a director of AVITA Medical, received two equity awards with a grant date of January 20, 2026: 22,214 restricted stock units (RSUs) and an option grant covering 16,133 shares. The option exercise price is $3.77 per share (Nasdaq closing price on the grant date). Both awards were subject to and received stockholder approval on June 3, 2026. These are compensation awards (not open‑market purchases or sales).

Key Details

• Transaction dates: Grant date January 20, 2026; stockholder approval obtained June 3, 2026; Form 4 filed June 4, 2026.
• RSUs: 22,214 RSUs awarded; RSUs vest 12 months after the grant date (per footnote). Includes unvested RSUs.
• Options: 16,133 stock options granted with an exercise price of $3.77 per share (grant described as a derivative award).
• Cash reported: RSU award reflected as an acquisition (no cash paid); option grant reported with $0 cash outlay on grant (typical for option awards).
• Shares owned after transaction: not specified in the filing.
• Timeliness: Filing was submitted the day after stockholder approval and appears timely (not marked late).

Context RSUs are a deferred-share award that convert into common stock upon vesting (here, 12 months after the grant). Stock options give the holder the right to buy shares at the stated strike ($3.77) — they are not exercised by this filing. Grants to non-executive directors are commonly part of routine compensation and do not by themselves indicate immediate buying or selling sentiment.